609 related articles for article (PubMed ID: 1357550)
1. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
2. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
4. Diurnal change of bronchial caliber and airway responsiveness in asthmatics during long-term treatment with long-acting beta 2-agonist salmeterol.
Dottorini ML; Tantucci C; Peccini F; Grassi V; Sorbini CA
Int J Clin Pharmacol Ther; 1996 Oct; 34(10):438-43. PubMed ID: 8897082
[TBL] [Abstract][Full Text] [Related]
5. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
Pearlman DS; Chervinsky P; LaForce C; Seltzer JM; Southern DL; Kemp JP; Dockhorn RJ; Grossman J; Liddle RF; Yancey SW
N Engl J Med; 1992 Nov; 327(20):1420-5. PubMed ID: 1357554
[TBL] [Abstract][Full Text] [Related]
6. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment.
Drotar DE; Davis EE; Cockcroft DW
Ann Allergy Asthma Immunol; 1998 Jan; 80(1):31-4. PubMed ID: 9475563
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term salmeterol treatment on exercise-induced asthma.
Nelson JA; Strauss L; Skowronski M; Ciufo R; Novak R; McFadden ER
N Engl J Med; 1998 Jul; 339(3):141-6. PubMed ID: 9664089
[TBL] [Abstract][Full Text] [Related]
9. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
10. Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo.
Cheung D; Wever AM; de GOEIJ JA; de GRAAFF CS; Steen H; Sterk PJ
Am J Respir Crit Care Med; 1998 Sep; 158(3):792-6. PubMed ID: 9731006
[TBL] [Abstract][Full Text] [Related]
11. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
Simons FE
N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125
[TBL] [Abstract][Full Text] [Related]
12. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
[TBL] [Abstract][Full Text] [Related]
13. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
[TBL] [Abstract][Full Text] [Related]
14. Salbutamol tolerance to bronchoprotection: course of onset.
Stewart SL; Martin AL; Davis BE; Cockcroft DW
Ann Allergy Asthma Immunol; 2012 Dec; 109(6):454-7. PubMed ID: 23176887
[TBL] [Abstract][Full Text] [Related]
15. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
Haney S; Hancox RJ
Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
[TBL] [Abstract][Full Text] [Related]
16. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
17. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
18. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics.
Wong AG; O'Shaughnessy AD; Walker CM; Sears MR
Eur Respir J; 1997 Feb; 10(2):330-6. PubMed ID: 9042628
[TBL] [Abstract][Full Text] [Related]
20. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
Pearlman DS
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
